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Abstract 
Objective: This study was designed to determine the relationship between Mycobacterium avium subspecies paratu-
berculosis (MAP) infection and selenium‑dependent glutathione peroxidase (GPx) activity, in the blood of humans and 
cattle infected with MAP.
Design: MAP infection status and GPx activity were determined in sera from 42 cattle, a group of 27 patients with 
Crohn’s disease and 27 of their healthy biological relatives, and a group of 66 subjects with various diseases other than 
Crohn’s disease and 34 non‑related healthy subjects.
Results: GPx activity was significantly higher overall in the case of MAP infection in both humans and cattle. The 
mean value for GPx activity was 1.59 ± 0.65 units/ml in MAP positive cattle compared to 0.46907 ± 0.28 units/ml in 
healthy cattle sera, where a unit was defined as one mmol/minute (P < 0.01). The mean value of the GPx activity in 
MAP negative humans clinical sera was 0.42367 ± 0.229 units/ml compared to 0.80941 ± 0.521 in MAP positive sera 
in a study comparing Crohn’s disease patients to their healthy relatives. The mean activity in MAP negative humans 
was 0.4702 ± 0.1299 compared to 0.6510 ± 00.1665 units/ml in positive samples in a randomized field study of 100 
subjects.
Conclusion: This study demonstrated a strong correlation between MAP and the elevation of GPx activity. This 
was especially evident in Crohn’s patients, which further supports the association of MAP and Crohn’s disease. GPx 
activity may also be used to predict MAP infection status and to show that Crohn’s disease patients who are infected 
with MAP have higher tendency to develop oxidative stress than Crohn’s disease patients who are negative for the 
bacteria.
Keywords: Crohn’s disease, Mycobacterium paratuberculosis, MAP, Glutathione peroxidase, Oxidative stress, Type I 
diabetes
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Background
Mycobacterium avium subspecies paratuberculosis 
(MAP) is implicated in the etiology of multiple diseases 
including Crohn’s disease (CD) and both type I and type 
II diabetes mellitus (DM) in humans [1–4]. Several studies 
have proposed that MAP is a causative factor in type 1 
diabetes due to cross-reactivity between MAP and human 
proteins [5, 6]. It is also known to be a causative agent of 
Johne’s disease, a bovine disease similar to CD in humans 
[7]. MAP is an obligate intracellular pathogen, living 
inside the macrophages of the infected host [8]. MAP 
increases the suitability of the macrophage as a host and 
prevents its own destruction by preventing the acidifica-
tion of the phagosome [9, 10]. This is done by preventing 
the fusion of the lysosome and the phagosome into the 
Open Access
Gut Pathogens
*Correspondence:  saleh.naser@ucf.edu 
Burnett School of Biomedical Sciences, College of Medicine, University 
of Central Florida, 4110 Libra Drive, Orlando, FL, USA
†A. Qasem and A. Abdel‑Aty are co‑first authors.
Page 2 of 9Qasem et al. Gut Pathog  (2016) 8:12 
phagolysosomal complex [9, 10]. MAP is also resistant to 
destruction even in an acidified, mature phagolysosome 
[11]. The primary mechanism for the destruction of MAP 
resistant to phagolysosomal degradation is the induc-
tion of apoptosis of the infected macrophage through a 
tumor necrosis factor α (TNF-α) dependent mechanism 
[12, 13]. There is evidence that Mycobacteria evade this 
host response by inhibiting apoptosis, and by stimulat-
ing necrosis, which allows the bacteria to disseminate [14, 
15]. Furthermore, in an active infection the body’s abil-
ity to clear apoptotic cells may be outpaced. The delay in 
clearance results in the apoptotic cell bodies losing their 
membrane integrity and becoming secondary necrotic 
cells [16]. In the case of the apoptosis of an active mac-
rophage, this includes the leaking of lysosomal content. 
This includes reactive oxygen species (ROS), which leads 
to systemic inflammation and oxidative stress.
Selenium is an important trace element that has many 
biological functions, particularly through its incorpo-
ration into multiple selenoproteins. There are 25 such 
proteins in humans [17]. One of these proteins is glu-
tathione peroxidase (GPx), an antioxidant enzyme found 
in all eukaryotes. This enzyme uses glutathione to reduce 
hydrogen peroxide, lipid peroxides, and hydroperoxides 
[18]. Though selenium has been shown to have insulin 
mimetic properties, elevated selenium has been associ-
ated with diabetes [19–21]. This is possibly due to the 
selenium found in GPx. Elevated GPx, as well as the cor-
responding elevation in selenium, is associated with type 
I diabetes [22]. GPx has also recently been implicated in 
the pathophysiology of type II diabetes. McClung et  al. 
[23] found that overexpression of GPx in mice resulted 
in the development of hyperinsulinemia, hyperglycemia, 
and decreased insulin sensitivity, all of which are indica-
tors of type II diabetes. Though the mechanism of this 
is poorly understood, they proposed that excessive GPx 
quenched peroxides too quickly, resulting in less ROS-
mediated inhibition of protein-tyrosine phosphatases 
[23]. Inhibition of these phosphatases, which dephospho-
rylate insulin receptors, increases insulin sensitivity [24]. 
Xi Yan et al. [25] found that decreasing selenium intake 
in mice overexpressing GPx decreases the hyperinsuline-
mia, hyperglycemia, and insulin resistance caused by the 
elevated GPx expression. Excessive dietary selenium, on 
the other hand, has been found to upregulate GPx and 
result in higher insulin resistance [26, 27]. A similar trend 
was found in humans [28]. Selenoproteins are also upreg-
ulated as a result of oxidative stress [29].
The association between infection and GPx activity 
is poorly understood. The objective of this study was to 
assess the potential association between MAP infection 
and the activity of selenium-dependent GPx in bovine 
and human samples. We hypothesize that the oxidative 
stress caused by MAP infection will result in elevated 
GPx activity. The oxidative stress associated with MAP 
infection may have broad systemic effects and may be 
clinically relevant to diseases including CD and diabetes.
Methods
Bovine samples
Sera samples from healthy and MAP infected cattle were 
kindly provided by Dr. Michael Collins (University of 
Wisconsin). Bovine samples were confirmed for MAP 
infection using the IDEXX Mycobacterium paratuber-
culosis (M. pt.) Antibody Test Kit (IDEXX Laboratories, 
Westbrook, ME, USA) following manufacturer instruc-
tions. A S/P less than or equal to 0.60 was considered 
negative and a S/P greater than or equal to 0.70 was con-
sidered positive. Sera from 21 MAP infected cattle and 21 
healthy cattle were then included in this study.
Human samples
Sample processing
Human blood samples were collected in two separate 
sets where each subject provided three 6.0-ml K2-EDTA 
tubes. All clinical samples were collected following Uni-
versity of Central of Florida-Institutional Review Board 
approval number IRB00001138. A total of 27 human 
blood samples were collected from CD patients along 
with 27 samples of their healthy biological family mem-
bers (parents or siblings), those samples were collected at 
the University of Florida (UF). An additional randomized 
100 blood samples used in earlier studies were also 
included. Clinical samples were collected blindly with no 
prior knowledge of MAP diagnosis or other health condi-
tions. Buffy coat preparations and plasma samples were 
separated and stored at −20 °C.
DNA extraction and nested PCR analysis
DNA extraction for PCR analysis was performed on puri-
fied buffy coat samples. Each sample was re-suspended 
in 100 μL of TE buffer and then incubated at 100 °C for 
30  min. The re-suspended solution was then placed in 
an ice bath for 15 min, after which it was centrifuged for 
10 min at 4 °C at 12,000 rpm (18,500g). After centrifuga-
tion, the supernatant was extracted in 200 μL of phenol/
chloroform/isoamyl alcohol (1:1:24 v/v; Acros Organics, 
Morris Plains, NJ, USA) was added. The solution was 
mixed and centrifuged for 5  min at 4  °C at 12,000  rpm 
(18,500g). The pellet, containing the nucleic acid, was 
then washed, dried, and re-suspended in 50 μL of sterile 
water [3].
Detection of MAP DNA using nested PCR (nPCR) was 
based on the MAP-specific IS900 derived oligonucleo-
tide primers [3]. As shown in Table 1, P90 and P91 prim-
ers were used for the amplification of 398 bp in the first 
Page 3 of 9Qasem et al. Gut Pathog  (2016) 8:12 
round of amplification and AV1 and AV2 primers, were 
used to amplify a 298 bp internal sequence. Each primary 
PCR reaction used 10  µL of DNA template and 40  µL 
of PCR buffer, which consists of 5 mM MgCl2, 0.2 mM 
dNTP, 2 µM primers, and 2.5 U Platinum Taq polymerase 
(Invitrogen, Carlsbad, CA, USA) or 1 U TFL DNA poly-
merase (Promega, Madison, WI, USA). Each secondary 
round of PCR used the same ingredients, except different 
primers were used and 5 µL of the product of the primary 
round was used instead of the DNA template. Negative 
controls for the PCR were prepared in which sterile water 
or TE buffer was added instead of the DNA template (in 
the primary amplification) or the primary product (in the 
secondary amplification). These negatives were prepared 
in parallel with the samples. Positive controls were also 
prepared using MAP DNA from strain ATCC 43015. The 
amplification product size was assessed on 2  % agarose 
gel.
Selenium‑dependent GPx activity measurement
Enzyme assay
Glutathione peroxidase works by reducing peroxides by 
oxidizing glutathione. The glutathione is then restored 
for further cycles of catalysis (Fig.  1). The rate-limiting 
step of this reaction is that in which the oxidized glu-
tathione used to reduce the peroxide is restored via the 
oxidation of NADPH. NADPH absorbs at 340  nm. The 
selenium-dependent GPx activity was measured by 
using the Sigma-Aldrich GPx Cellular Activity Assay Kit 
(Sigma-Aldrich, St. Louis, MO, USA) following manufac-
turer instructions.
Statistical analysis
Samples were analyzed for significance using unpaired, 
two-tailed t tests. SigmaPlot software was used. P values 
of less than 0.05 were considered significant.
Results
MAP prevalence in human samples
We performed nPCR on DNA extracts isolated from all 
human blood samples in order to analyze for the pres-
ence of MAP-specific IS900 gene according to Naser 
et al. protocol [3]. The overall prevalence of MAP among 
154 human blood samples was 32 %. MAP was positive in 
the blood of 40 % of CD patients compared to 29.9 % in 
non-CD patients. Specifically MAP was also positive in 
11/27 (40 %) of CD patients and in 2/27 (7 %) in healthy 
biological family members. Interestingly, 33  % (7 out of 
21) of patients with type II diabetes and 44 % (7 out of 16) 
pre-diabetic patients were also MAP positive. Patients 
were considered to be pre-diabetic if they had a fasting 
blood sugar level between 100 and 125 mg/dl, if the two-
hour glucose levels was between 140 and 199  mg/dl in 
an oral glucose tolerance test, or if they had a glycated 
hemoglobin (A1C) level between 5.7 and 6.4. Figure  2 
illustrates the detection of MAP IS900 gene on 2 % aga-
rose gel following nPCR analysis of 100 randomized 
human blood samples (lanes 1–100).
Table 1 Primers and amplification conditions used for PCR
Primer Oligonucleotide sequence (5′–3′) Gene Amplification conditions Product 
size (bp)
References
P90, P91 GTTCGGGGCCGTCGCTTAGG,  
GAGGTCGATCGCCCACGTGA
IS900 95 °C for 5 min, then 34 cycles of 95 °C for 1 min, 58 °C for 
1.5 min, 72 °C for 1.5 min. Final extension of 10 min at 
72 °C
398 Naser et al. [3]
AV1, AV2 ATGTGGTTGCTGTGTTGGATGG,  
CCGCCGCAATCAACTCCAG
IS900 95 °C for 5 min, then 34 cycles of 95 °C for 1 min, 58 °C for 
1.5 min, 72 °C for 1.5 min. Final extension of 10 min at 
72 °C
298 Naser et al. [3]
Fig. 1 Reduced and oxidized states of glutathione
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Selenium‑dependent GPx levels were elevated in MAP 
infected bovine samples
Bovine sera were confirmed for presence of anti-MAP 
IgG. Consequently, a total of 21 cattle sera samples from 
animals diagnosed with Johne’s disease (MAP positive) 
and 21 sera from healthy cattle (MAP negative) were 
selected for the study. All 42 sera were analyzed for of 
GPx activity. The average level of GPx was 0.46907 ± 0.28 
units/ml in healthy cattle sera control compared to 
1.590  ±  0.65 units/ml in sera from cows infected with 
MAP, where a unit was defined as one mmol/minute. The 
MAP positive samples had a significantly higher activ-
ity level, with a difference in means of 1.122 (95 % confi-
dence interval 0.810–1.435; P < 0.01) (Table 2). Figure 3a 
shows a scatter plot of selenium-dependent GPx activity 
for MAP negative and MAP positive samples.
Selenium‑dependent GPx activity was elevated in MAP 
infected humans among Crohn’s patients and their healthy 
relatives
The average level of GPx activity was 0.80941  ±  0.521 
units/ml in the MAP positive samples, while the aver-
age enzyme activity in MAP negative samples was found 
to be 0.42367 ±  0.229 units/ml. This result reveals that 
MAP infection has a significant influence on GPx activ-
ity, with a difference in means of 0.387 (95 % confidence 
interval 0.182–0.592; P < 0.01) (Fig. 3b).
The difference between selenium‑dependent GPx activity 
in Crohn’s Disease and in healthy individuals was not 
significant
In order to confirm that the elevation of GPx activ-
ity level was due to MAP infection alone, and not due 
to CD status, we measured the average of GPx activ-
ity in healthy individuals and CD patients separately. 
The average GPx activity was found to be 0.54 ±  0.414 
units/ml and 0.493 ± 0.301 units/ml in CD and healthy 
patients respectively. While the mean GPx enzymatic 
activity in CD patients was higher by 0.0469, our results 
showed that there was no significant difference between 
both groups (95  % confidence interval −0.245 to 0.151; 
P = 0.636) (Fig. 3c). The gender ratio and age distribution 
between the two groups was comparable between the 
two groups (Table 3).
Selenium‑dependent GPx activity was elevated in MAP 
infected Crohn’s patients
As mentioned earlier, out of 27 CD patients, a total of 11 
were tested as MAP positive, while 16 were MAP nega-
tive. The average GPx activity in CD patients who had 
the MAP infection was 0.7593  ±  0.537 units/ml, while 
the GPx activity was found to be 0.389 ± 0.213 units/ml 
in CD patients without MAP infection. The difference 
in means was 0.37 (95 % confidence interval 0.07–0.675; 
P = 0.019). (P = 0.019) (Fig. 3d). Furthermore only 2 of 
Fig. 2 Agarose gels illustrating the presence or absence of MAP‑IS900 gene following nPCR. The PCR products following the second round of nPCR 
were analyzed on 2 % agarose gel. M represents molecular weight marker in bp. = represents negative control from second round of amplifica‑
tion. − represents negative control from first round of amplification. TE represents TE buffer negative control. + represents positive control prepared 
from MAP DNA strain ATCC 43015. 1–100 represents patient samples
Table 2 GPx enzyme average activity and MAP presence in bovine and human blood samples
Number of samples/total Source MAP diagnosis Average GPx activity (units/ml) P value
21/42 Bovine Negative 0.469 ± 0.28 <0.01
21/42 Bovine Positive 1.590 ± 0.65
105/154 Human Negative 0.452 ± 0.176 <0.01
49/154 Human Positive 0.693 ± 0.30
16/27 CD patients Negative 0.389 ± 0.213 <0.05
11/27 CD patients Positive 0.7593 ± 0.537
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the 27 healthy relatives used as controls, or 7.4 %, were 
infected with MAP.
Selenium‑dependent GPx activity was elevated 
among MAP infected humans in randomized field study
Among randomized blood samples from 100 subjects, 36 
were determined to be MAP positive as shown in Fig. 2. 
The average of GPx activity level in 36 MAP positive 
clinical samples was 0.6510  ±  00.1665 units/ml com-
pared 0.4702 ± 0.1299 in 64 MAP negative clinical sam-
ples (P < 0.01) (Table 2). The GPx activity in each clinical 
sample is illustrated in Fig. 3e. We further examined the 
difference in GPx activity according to disease diagnosis, 
but there was no significant difference in MAP negative 
clinical samples between healthy controls and subjects 
with diseases. Disease states, including type 2 diabetes 
Fig. 3 a Scatter plot of selenium‑dependent GPx activity for MAP negative and MAP positive bovine samples. b Scatter plot of selenium‑dependent 
GPx activity for MAP negative and MAP positive samples among CD patients and healthy relatives. c Scatter plot of selenium‑dependent GPx activity 
for Healthy and CD individuals. d Scatter plot of selenium‑dependent GPx activity for MAP negative and MAP positive among CD patients. e Scatter 
plot of selenium‑dependent GPx activity for MAP negative and MAP positive in randomized field study
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and pre-diabetes, were not found to have a significant 
impact on GPx activity. It is notable, however, that in 
all disease states MAP positive individuals still have 
higher enzymatic activity than MAP negative individuals 
(Fig. 4).
Discussion
Oxidative stress and the resulting GPx up-regulation may 
have significant implications on disease pathophysiology. 
In particular, long-term up-regulation of GPx may cause 
insulin resistance and disruptions in insulin signaling 
[23]. Furthermore, oxidative damage has recently been 
an area of focus for research into inflammatory condi-
tions such as CD and inflammatory bowel disease (IBD). 
Despite this, the relationship between MAP infection and 
oxidative stress has not been clearly established. The pur-
pose of our study was therefore to elucidate the relation-
ship between MAP infection and GPx activity in plasma. 
This makes it possible to find the differences in oxida-
tive stress level in CD patients with the presence and 
absence of MAP infection, which may have implications 
on the treatment of these patients. We acquired bovine 
and human samples, tested them for MAP infection, and 
measured their GPx activity.
We found that the enzymatic activity of GPx was sig-
nificantly higher in cows as well as among two separate 
groups of human subjects that are infected with MAP, 
where significance was defined as P < 0.05. This matched 
the expected trend. We chose to keep the data for the 
two cohorts of human patients separate, as the samples 
for these two groups were collected separately and for 
different reasons. The CD patients and their healthy rela-
tives were used primarily to determine if the observed 
trend was caused by CD status, or if it was caused by 
MAP infection. We propose to exclude CD as a potential 
cause of the observed trend due to the previously estab-
lished relationship between MAP and CD [1, 7, 30–33]. 
The biological relationships present in this group was 
ideal for determining the effects of CD, as any observ-
able difference in GPx activity could be attributed to the 
disease status, rather than hereditary environmental fac-
tors. However, in determining the effect of MAP on GPx 
activity, we determined that a randomized study would 
be preferable, and would better reflect the prevalence of 
MAP in subjects at large. It is worth noting, however, that 
when all human clinical samples were combined, MAP 
positive samples still had significantly elevated GPx activ-
ity when compared to MAP negative samples (P < 0.01).
We found that there was there no significant difference 
in GPx activity in MAP negative samples from CD and 
non-CD samples. However, GPx activity was elevated 
in all clinical samples which were positive for MAP 
Table 3 Demographics of  Crohn’s patients and  healthy 
relatives
Group Age range Average age Gender ratio (M/F)
Relatives 12–65 45 9/18
Crohn’s 16–56 32 8/19
Fig. 4 Average GPx activity levels in plasma samples from blood samples identified as as MAP negative and positive individuals according to 
according to disease status
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regardless of the source of samples. While it was surpris-
ing that an inflammatory condition like CD, as well as 
other disease states, has no significant effect on GPx, this 
makes a stronger case that MAP infection may be playing 
a role in the elevation in enzymatic activity. We further 
excluded CD status as a potential confounding factor in 
the human samples by comparing CD patients infected 
with MAP with those not infected with MAP. We found 
that there was still a significant correlation between MAP 
infection and GPx even when CD status was controlled 
for (P < 0.05).
The prevalence of MAP in CD patients was 40 % com-
pared to 7.4 % MAP in healthy relatives (P < 0.01), indi-
cating that the CD patients were more susceptible to 
MAP infection. This is consistent with published reports 
[7, 30–32, 34–36]. This study is the first to investigate the 
association of MAP and CD did using healthy relatives 
as controls. Our findings strengthen the growing body of 
literature supporting the correlation between MAP and 
CD. Of course the role of MAP in CD etiology remains 
debated but genetic susceptibility especially single nucle-
otide polymorphism in key genes in patients with CD 
may promote MAP infection [7, 34–36].
The randomized component of this study revealed 
a 36  % MAP prevalence. Since these patients were ran-
domly selected, this is likely to reflect the true prevalence 
of MAP infection in the community. The differences 
in MAP prevalence between the healthy relatives of 
Crohn’s patients and the community at large may be due 
to complex genetic and environmental factors yet to be 
elucidated, and which warrant further study. It is worth 
noting that MAP has been associated with several auto-
immune diseases including CD, T1D, Blau syndrome, 
Hashimoto’s thyroiditis, and multiple sclerosis [37–41]. 
In fact, Sechi and Dow [39] have discussed in a recent 
review article that many subjects among us might be 
positive for MAP because of suffering from other dis-
eases where MAP might be a culprit. The cross reactivity 
between MAP antigens and host proteins in patients with 
these diseases could be the base for molecular mimicry 
where exposure to MAP could lead to reprograming of 
the immune system and ultimately leading to produc-
tion of autoantibodies and tissue damage. It is a fact that 
MAP is wide-spread in the environment and now is part 
of the food chain and genetic predisposition in key genes 
invites susceptibility to MAP infection. Interestingly, 
Sechi’s group has recently reported that epitope homol-
ogy between human interferon regulatory factor 5 of 
Epstein-Barr virus and M. avium subsp. paratuberculosis 
induces a specific humoral and cellular immune response 
in multiple sclerosis patients [44]. This report expands on 
the molecular mimicry between pathogens versus host to 
branch out molecular mimicry to be between pathogens. 
Consequently, remote MAP infection in humans may be 
possible. So the lack of clinical data on controls especially 
with regard to diagnosis for other diseases may play a fac-
tor in the prevalence of MAP in subjects included in this 
study.
The pathogenesis mechanism of CD involves interac-
tion between environmental agents, genetic and immu-
nologic abnormalities [42]. Recently, the role of reactive 
oxygen species has been an area of interest to study 
IBD pathophysiology [43]. Granulocyte accumulation is 
increased in the gut mucosa where inflammation is active 
in IBD patients and those cells secrete different inflam-
matory mediators [42]. It has been shown that mucosal 
inflammation impairs antioxidant defense and the tissues 
become more liable to oxidative damage [44]. Increasing 
GPx antioxidant activity is a result of elevation in free 
radical levels. It is unknown if granulocyte accumulation 
is increased in CD patients who are infected with MAP in 
comparison to CD patients who are not. This will lead to 
different phenotypes of CD patients who are MAP posi-
tive or negative with differences in oxidative stress and 
free radical levels in according to the disease state which 
will be reflected in the clinical status of those patients. 
In T1D, a significant homology was reported between 
human glutamic Acid decarboxylase 65 (GAD65) and 
MAP HSP65 [37, 38]. This cross reactivity supports 
molecular mimicry between host and microbe inter-
action [37]. Future studies are also needed to evaluate 
the enhanced disease state that may be present in MAP 
infected Crohn’s patients and those considered controls.
We also considered smoking, gender, and age as poten-
tial confounding factors. There was no significant dif-
ference in GPx activity between males and females or 
smoking habits. The GPx enzymatic activity of patients 
above 40 was overall lower, but the difference was not 
significant. Overall there was no significant correlation 
between age and GPx activity (r  =  0.0648, P  =  0.74). 
None of these factors proved to have an effect on our 
data.
While significant in both human and bovine samples, 
the difference in average GPx activity between MAP 
infected and non-infected samples was much more 
extreme in the bovine samples. This is possibly because 
bovine are capable of a more robust response, or because 
they have a larger bacterial load, than humans. There are 
also less confounding factors in bovine samples, as cattle 
used as livestock are fed similar diets and live in similar 
conditions, as opposed to humans in which these fac-
tors vary widely. As such, cows may be a purer model for 
study, and the results from the bovine samples may be 
more representative.
The unique progression of MAP infection causes sys-
temic inflammation and oxidative stress. It is possible 
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that GPx production is up-regulated in order to com-
pensate for this. Though on the short term this may off-
set the negative effects of the infection, on the long term, 
particularly in chronic infections, it may cause its own 
problems. While the long-term oxidative stress caused by 
MAP infection may not be fatal, it may have a wide range 
of deleterious systemic effects. It is possible that other 
species of Mycobacteria have similar effects. Future stud-
ies will further elucidate the relationship between MAP 
infection, GPx up-regulation, glucose homeostasis, as 
well as the clinical status of CD patients.
Conclusion
The GPx enzymatic activity of selenium dependent GPx 
was significantly higher in both bovine and human serum 
samples infected with MAP. The consistent correlation 
between MAP infection and GPx activity potentially may 
be used to predict MAP infection status. We posit that 
the presence of this bacterium causes systemic inflam-
mation and oxidative stress, which on the long-term may 
cause disruptions in insulin signaling and have a delete-
rious effect on insulin sensitivity. Via this process MAP 
infection could be involved in the pathophysiology of 
insulin resistance and in the elevation of oxidative stress 
level in CD patients who are infected with MAP.
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